• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazolecarboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Thiazolecarboxylic acids and derivatives

Recent Advances in the Study of 2-(prop-2-en-1-yl)amino-1,3-thiazole-5-carboxylic acid (CAS: 1384798-69-9)

The compound 2-(prop-2-en-1-yl)amino-1,3-thiazole-5-carboxylic acid (CAS: 1384798-69-9) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. This thiazole derivative, characterized by its unique structural features, has been the subject of several studies aimed at exploring its biological activities, synthetic pathways, and pharmacological properties. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its significance in drug discovery and development.

Recent studies have focused on the synthesis and optimization of 2-(prop-2-en-1-yl)amino-1,3-thiazole-5-carboxylic acid, with particular emphasis on improving its yield and purity. A 2023 publication in the Journal of Medicinal Chemistry detailed a novel synthetic route that utilizes microwave-assisted organic synthesis (MAOS) to achieve higher efficiency and reduced reaction times. The study reported a yield of 85% under optimized conditions, significantly higher than traditional methods. Furthermore, the synthesized compound was characterized using advanced spectroscopic techniques, including NMR and mass spectrometry, confirming its structural integrity.

In terms of biological activity, 2-(prop-2-en-1-yl)amino-1,3-thiazole-5-carboxylic acid has demonstrated promising results in preclinical studies. A recent investigation published in Bioorganic & Medicinal Chemistry Letters revealed its potent inhibitory effects against a range of bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The compound exhibited a minimum inhibitory concentration (MIC) of 2 μg/mL, comparable to established antibiotics. Molecular docking studies suggested that its mechanism of action involves binding to the bacterial enzyme dihydrofolate reductase (DHFR), thereby disrupting folate synthesis.

Beyond its antimicrobial properties, this thiazole derivative has also shown potential as an anticancer agent. A 2024 study in European Journal of Medicinal Chemistry explored its effects on various cancer cell lines, including breast (MCF-7) and lung (A549) cancer cells. The compound induced apoptosis via the intrinsic mitochondrial pathway, as evidenced by increased caspase-3 activity and DNA fragmentation. Notably, it displayed selective cytotoxicity towards cancer cells while sparing normal fibroblasts, suggesting a favorable safety profile. These findings underscore its potential as a lead compound for further development in oncology.

In addition to its direct therapeutic applications, 2-(prop-2-en-1-yl)amino-1,3-thiazole-5-carboxylic acid has been investigated for its role in drug delivery systems. A recent study in International Journal of Pharmaceutics demonstrated its utility as a linker in prodrug formulations. The compound's carboxylic acid moiety facilitated conjugation with various drug molecules, enabling controlled release under physiological conditions. This approach holds promise for improving the pharmacokinetics and bioavailability of poorly soluble drugs.

In conclusion, the latest research on 2-(prop-2-en-1-yl)amino-1,3-thiazole-5-carboxylic acid (CAS: 1384798-69-9) highlights its multifaceted potential in chemical biology and medicinal chemistry. From its optimized synthesis and antimicrobial activity to its anticancer properties and applications in drug delivery, this compound represents a valuable scaffold for future drug development. Continued exploration of its mechanisms of action and structure-activity relationships will be crucial for unlocking its full therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)